about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Read More
3.52
-0.03
(-0.85%)
7.0M
XNAS Volume
High vol.+gain this week
XNAS 08 May, 2026 3:13 PM (EDT)
Board Meeting
The next board meeting for Mannkind Corp is on 14 May 2026 for the purpose of MannKind Corp Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..